#6OF 12
↗
Company profileabcentra.com ↗
Abcentra
Abcentra is a clinical-stage biopharmaceutical company focused on treatment options for patients with coronary artery disease (CAD).
- Headquarters
- Los Angeles, California, United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1 to 10Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2006Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 2 supported appearances ↗Source: RevenueBase lists
What does Abcentra do?
The company’s clinical-stage product Orticumab is a monoclonal antibody against oxidized LDL (OxLDL). Abcentra is developing Orticumab for secondary prevention of cardiac events after acute coronary syndrome (ACS).
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
#7OF 12
↗Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
BADGE PREVIEW
Open the published source list.
Open the published source list.Company information
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated October 8, 2026. How the company lists are built.
Help keep this profile accurate
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Find your next account
Explore company profiles →One company is just the start.
Explore more companies by name, headquarters and business focus.